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Introduction
In hypertrophic cardiomyopathy (HCM), the pathogenesis
of asymmetrical left ventricular (LV) wall thickening is
based upon a complex interplay of molecular pathways
and is still largely unclarified. Since cariporide (an Na
+/H
+
exchange blocker) has been proven effective in several
pressure overload (animal) models by inhibiting the hyper-
trophic response, we hypothesized that cariporide might
prevent or diminish the development of hypertrophy seen
in HCM. Therefore, we treated transgenic mice (homozy-
gous cMyBP-C null mice) with cariporide and subjected
them to cardiomagnetic resonance imaging (CMR).
Purpose
To determine the effect of cariporide on the development
of LV hypertrophy in hypertrophic cardiomyopathy.
Methods
We used 19 male homozygous cMyBP-C null mice in our
study, of which 10 animals were treated with standard
animal chow containing 6000 ppm cariporide, beginning
at 5 weeks of age for 2 months. In order to evaluate LV
mass and function, the animals underwent state-of-the-
art CMR-imaging at 5 weeks and at 3 months of age. The
control group consisted of wildtype animals (n=14) who
were scanned at 6 months of age. A state-of-the-art 9.4
T scanner (Bruker, Erlangen) was used for CMR acquisi-
tions. Off-line analysis was performed using dedicated
software (Qmass, Medis, Leiden).
Results
There were no significant differences in global and
regional LV mass and LV function between the treated
and untreated mice at 5 weeks (data not shown) and
3 months of age (depicted in table 1). Furthermore,
transgenic mice of 5 weeks old already showed a signifi-
cant increased LV mass (corrected for bodyweight)
with respect to wildtype animals (3.37 ± 0.43 (x10
-3)v s
2.07 ± 0.31 (x10
-3), p<0.01).
Conclusions
Our study demonstrated that cariporide has no effect on
the regression of LV hypertrophy in homozygous
cMyBP-C null (HCM) mice after two months of treat-
ment. Apparently, blockade of the Na
+/H
+ exchanger
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Table 1 CMR-derived LV dimensions and mass of
homozygous cMyBP-C null mice at 3 months of age
Cariporide
(n=10)
Non-treated
(n=9)
P-value
LV mass (mg) 94.6 ± 12.6 88.6 ± 8.3 ns
LV mass/body weight (10
-3) 3.16 ± 0.34 3.07 ± 0.43 ns
LVEDV (ul) 91.8 ± 13.4 89.7 ± 12.7 ns
LVESV (ul) 68.7 ± 11.3 65.8 ± 12.9 ns
LVEF (%) 25.4 ± 3.9 27.0 ± 4.1 ns
Mean septal wall
thickness (mm)
0.82 ± 0.06 0.80 ± 0.62 ns
Mean LV wall
thickness (mm)
0.89 ± 0.09 0.84 ± 0.08 ns
Maximal septal wall
thickness (mm)
1.17 ±0.17 1.15 ± 0.14 ns
Maximal LV wall
thickness (mm)
1.29 ± 0.18 1.32 ± 0.16 ns
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Whether cariporide is able to prevent hypertrophy in
HCM needs further evaluation.
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